
GC13037
Silmitasertib
Also listed as CX-4945 (Silmitasertib)
CX-4945 (Silmitasertib) (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'
ChemicalCAS1009820-21-6MW349.77FormulaC19H12ClN3O2
- CAS number
- 1009820-21-6
- Molecular weight
- 349.77
- Formula
- C19H12ClN3O2
- Solubility
- ≥ 8·74mg/mL in DMSO
- InChIKey
- MUOKSQABCJCOPU-UHFFFAOYSA-N
- Catalogue number
- GC13037
- Brand
- GLPBIO
Computed properties PubChem CID 24748573 · XLogP 4.4 · TPSA 75.1 Ų · H-bond donors 2
- XLogP
- 4.4
- TPSA
- 75.1 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 3
- Heavy atoms
- 25
SMILES C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4
Computed descriptors from PubChem (CID 24748573), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il